Antibacterial Soap Is No More Effective Than Regular Soap

For decades, consumers reached for antibacterial soaps, believing they offered superior protection against germs. This perception was upended in 2016 when the FDA ruled that manufacturers had not proven these products were any better at preventing illness than regular soap and water. The ruling specifically targeted triclosan and 18 other active ingredients commonly found in these soaps. Triclosan, an antimicrobial agent developed in the 1960s and initially used in hospitals, became a widespread addition to household products in the 1990s. However, years of research failed to produce evidence that it provided any extra benefit in a typical home setting.

The effectiveness of plain soap lies in its basic chemistry. Soap molecules have a hybrid structure with a head that bonds with water and a tail that avoids it, preferring to link with oils and fats. This structure allows soap to act like a crowbar, prying germs and viruses from the skin. The friction from scrubbing lifts these captured microbes, and the water (Review) then rinses them away. This mechanical removal is remarkably effective at preventing the spread of germs.

Beyond the lack of added benefit, concerns grew over the potential long-term consequences of widespread triclosan use. Studies suggested that exposure to the chemical could contribute to the development of antibiotic-resistant bacteria, a significant public health concern. There were also findings that triclosan could have potential hormonal effects in the body. With no proven advantage to offset these risks, the FDA's decision marked a significant shift back to the basics, reaffirming that traditional soap and water remain the gold standard for everyday hand hygiene.